Ziprasidone oral capsules
Ziprasidone oral capsules is a pharmaceutical drug with 7 clinical trials. Historical success rate of 40.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
28.6%
2 of 7 finished
71.4%
5 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder
Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia
Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia
Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
Clinical Trials (7)
Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder
Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia
Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia
Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)
Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7